FISHing in the dark: How the combination of FISH and conventional karyotyping improves the diagnostic yield in CpG‐stimulated chronic lymphocytic leukemia
Adrian M. Dubuc(University of Toronto), Paola Dal Cin(Brigham and Women's Hospital), Olja Pulluqi(Brigham and Women's Hospital), Jesús María Hernández-Sánchez(Universidad de Salamanca), Jesús María Hernández‐Rivas(Universidad de Salamanca), Mirela Pulluqi(Brigham and Women's Hospital), Matthew S. Davids(Dana-Farber Cancer Institute), Jennifer R. Brown(Dana-Farber Cancer Institute), Kevin Hoang(Dana-Farber Cancer Institute), Cathy Schlich(Brigham and Women's Hospital)
Cited by 18
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k